Iranian Journal of Radiology

Published by: Kowsar

Outcome of Retinoblastoma Following Limited Sessions of Intra-Arterial Chemotherapy in Iran

Fariba Ghassemi 1 , Hossein Ghanaati 2 , * , Reza Karkhaneh 1 , Leila Boujabadi 1 , Seied ZiaTabatabaie 1 and Mohammad Taher Rajabi 1
Authors Information
1 Ocular Oncology and Retina and Vitreous Service, Farabi Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Radiology: August 01, 2014, 11 (3); e16958
  • Published Online: August 1, 2014
  • Article Type: Research Article
  • Received: December 17, 2013
  • Revised: June 18, 2014
  • Accepted: July 7, 2014
  • DOI: 10.5812/iranjradiol.16958

To Cite: Ghassemi F, Ghanaati H, Karkhaneh R, Boujabadi L, ZiaTabatabaie S, et al. Outcome of Retinoblastoma Following Limited Sessions of Intra-Arterial Chemotherapy in Iran, Iran J Radiol. 2014 ; 11(3):e16958. doi: 10.5812/iranjradiol.16958.

Copyright © 2014, Tehran University of Medical Sciences and Iranian Society of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci. 2005; 46(8): 2683-91[DOI][PubMed]
  • 2. Chan HS, Gallie BL, Munier FL, Beck Popovic M. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am. 2005; 18(1): 55-63[DOI][PubMed]
  • 3. Tsui JY, Dalgard C, Van Quill KR, Lee L, Grossniklaus HE, Edelhauser HF, et al. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci. 2008; 49(2): 490-6[DOI][PubMed]
  • 4. Augsburger JJ, Faulkner CB. Indirect ophthalmoscope argon laser treatment of retinoblastoma. Ophthalmic Surg. 1992; 23(9): 591-3[PubMed]
  • 5. Shields JA, Shields CL. Treatment of retinoblastoma with cryotherapy. Trans Pa Acad Ophthalmol Otolaryngol. 1990; 42: 977-80[PubMed]
  • 6. Chan MP, Hungerford JL, Kingston JE, Plowman PN. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation. Br J Ophthalmol. 2009; 93(7): 891-4[DOI][PubMed]
  • 7. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology. 2001; 108(11): 2116-21[PubMed]
  • 8. Schiedler V, Dubovy SR, Murray TG. Snare technique for enucleation of eyes with advanced retinoblastoma. Arch Ophthalmol. 2007; 125(5): 680-3[DOI][PubMed]
  • 9. Reese AB, Hyman GA, Tapley ND, Forrest AW. The treatment of retinoblastoma by x-ray and triethylene melamine. AMA Arch Ophthalmol. 1958; 60(5): 897-906[PubMed]
  • 10. Kiribuchi M. [Retrograde infusion of anti-cancer drugs to ophthalmic artery for intraocular malignant tumors]. Nihon Ganka Gakkai Zasshi. 1966; 70(11): 1829-33[PubMed]
  • 11. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004; 9(2): 69-73[DOI][PubMed]
  • 12. Ferris FL, 3rd, Chew EY. A new era for the treatment of retinoblastoma. Arch Ophthalmol. 1996; 114(11): 1412[PubMed]
  • 13. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008; 115(8): 1398-404[DOI][PubMed]
  • 14. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol. 2010; 128(3): 370-2[DOI][PubMed]
  • 15. Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011; 129(6): 732-7[DOI][PubMed]
  • 16. Brodie SE, Pierre Gobin Y, Dunkel IJ, Kim JW, Abramson DH. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol. 2009; 119(1): 13-22[DOI][PubMed]
  • 17. Shields CL, Ramasubramanian A, Rosenwasser R, Shields JA. Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma. Retina. 2009; 29(8): 1207-9[DOI][PubMed]
  • 18. Muen WJ, Kingston JE, Robertson F, Brew S, Sagoo MS, Reddy MA. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. Ophthalmology. 2012; 119(3): 611-6[DOI][PubMed]
  • 19. Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011; 129(11): 1399-406[DOI][PubMed]
  • 20. Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg. 2011; 114(6): 1603-8[DOI][PubMed]
  • 21. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology. 2006; 113(12): 2276-80[DOI][PubMed]
  • 22. Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, et al. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Ophthalmology. 2009; 116(3): 544-551 e1[DOI][PubMed]
  • 23. Ghassemi F, Rahmanikhah E, Roohipoor R, Karkhaneh R, Faegh A. Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy. Pediatr Blood Cancer. 2013; 60(4): 599-604[DOI][PubMed]
  • 24. Liu QL, Wang YF, Mao GS, Yang XJ, Sun YF, Miao LX, et al. [Analysis on the safety of ophthalmic artery cannulation for intra-arterial chemotherapy in 42 patients with intraocular stage retinoblastoma]. Zhonghua Er Ke Za Zhi. 2012; 50(10): 793-7[PubMed]
  • 25. Eagle RC, Jr, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol. 2011; 129(11): 1416-21[DOI][PubMed]
  • 26. Wilson MW, Jackson JS, Phillips BX, Buchanan J, Frase S, Wang F, et al. Real-time ophthalmoscopic findings of superselective intraophthalmic artery chemotherapy in a nonhuman primate model. Arch Ophthalmol. 2011; 129(11): 1458-65[DOI][PubMed]
  • 27. Vijayakrishnan R, Shields CL, Ramasubramanian A, Emrich J, Rosenwasser R, Shields JA. Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol. 2010; 128(11): 1427-31[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments